Prelude Therapeutics (PRLD)
(Delayed Data from NSDQ)
$2.55 USD
0.00 (0.00%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $2.46 -0.09 (-3.53%) 7:58 PM ET
3-Hold of 5 3
C Value C Growth A Momentum B VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/6/24 |
---|---|
Current Quarter | -0.48 |
EPS Last Quarter | -0.46 |
Last EPS Surprise | 0.00% |
ABR | 2.34 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -1.85 |
Next Year | -1.82 |
EPS (TTM) | -1.80 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | NA | NA |
# of Estimates | NA | NA | NA | NA |
High Estimate | NA | NA | NA | NA |
Low Estimate | NA | NA | NA | NA |
Year ago Sales | 0.00M | 0.00M | NA | NA |
Year over Year Growth Est. | NA | NA | NA | NA |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.48 | -0.50 | -1.85 | -1.82 |
# of Estimates | 3 | 3 | 3 | 3 |
Most Recent Consensus | -0.47 | -0.49 | NA | -2.07 |
High Estimate | -0.47 | -0.49 | -1.83 | -1.57 |
Low Estimate | -0.50 | -0.50 | -1.87 | -2.07 |
Year ago EPS | -0.45 | -0.47 | -2.02 | -1.85 |
Year over Year Growth Est. | -6.67% | -6.38% | 8.42% | 1.62% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 0 | 1 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 2 | 2 | 2 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.48 | -0.50 | -1.85 | -1.82 |
7 Days Ago | -0.48 | -0.50 | -1.85 | -1.82 |
30 Days Ago | -0.48 | -0.50 | -1.85 | -1.82 |
60 Days Ago | -0.46 | -0.49 | -1.84 | -1.86 |
90 Days Ago | -0.46 | -0.49 | -1.84 | -1.86 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.48 | -0.50 | -1.85 | -1.82 |
Zacks Consensus Estimate | -0.48 | -0.50 | -1.85 | -1.82 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.46 | -0.42 | -0.47 | -0.45 | NA |
Estimate | -0.46 | -0.47 | -0.50 | -0.58 | NA |
Difference | 0.00 | 0.05 | 0.03 | 0.13 | 0.05 |
Surprise | 0.00% | 10.64% | 6.00% | 22.41% | 9.76% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more